Author: clewmanta

A new artificial intelligence (AI) based ICU solution for predicting the likelihood of patient deterioration up to eight hours in advance has become the industry’s first ever device to receive clearance from the US Food and Drug Administration (FDA). from HospiMedica: AI-Based ICU Solution for Predicting Patient Deterioration Becomes Industry’s First Ever Device to Receive FDA Clearance

Developed by CLEW, the system gathers data from electronic health records, vital sign monitors and connected ICU devices, and uses machine learning models to calculate each person’s risk of their heart and blood flow becoming unstable. from FIERCE Biotech: CLEW’s AI cleared for predicting ICU patient decline

The U.S. FDA granted 510(k) clearance for Clew Medical Ltd.’s artificial intelligence (AI)-based solution that can predict hemodynamic instability in ICU patients eight hours in advance of deterioration. The system continuously monitors and stratifies patients by risk level to enable optimization of ICU resources. from BioWorld: Clew Medical receives FDA clearance for ICU device that predicts hemodynamic instability

CLEW Medical’s ICU tool uses machine learning models to identify patients whose conditions are likely to deteriorate. from EMR Industry FDA issues landmark clearance to AI-driven ICU predictive tool

The FDA has OK’d AI software that can predict worsening condition in ICU patients up to eight hours before the falloff produces symptoms. from AI in Healthcare: Proactive AI-based ICU patient monitoring cleared for market

CLEW Medical’s ICU tool uses machine learning models to identify patients whose conditions are likely to deteriorate. from Healthcare IT News: FDA issues landmark clearance to AI-driven ICU predictive tool

CLEWICU is a artificial intelligence (AI) based ICU solution that can “predict hemodynamic instability in adult patients.” from JPost: Israeli medtech company earns FDA approval for use of ICU predictive model

“We are proud to have received this landmark FDA clearance and deliver a first-of-its-kind product for the industry, giving healthcare providers the critical data that they need to prevent life-threatening situations,” said Gal Salomon, co-founder and CEO of CLEW Medical. from CTech: CLEW Medical receives FDA approval for AI-based tech to support adult ICU patient assessment

CLEWICU is the industry’s first-ever cleared device for predicting the likelihood of patient deterioration up to 8 hours in advance based on hemodynamic instability, enabling earlier evaluation and subsequent care plans from CLEW Medical Receives FDA Clearance for AI-Based Predictive Analytics Technology to Support Adult ICU Patient Assessment